Please refer to the special note regarding forward-looking statements in the company's quarterly report on Form 10-Q, which was filed today ... was primarily driven by $17.6 million of narsoplimab ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Cal, its Medicaid program, to every eligible resident regardless of immigration status. It's a significant expansion for an ...